CoChat

Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings

Atmaca, Murad, Kuloglu, Murat, Tezcan, Ertan, Unal, Ahmet · 2002 · Human Psychopharmacology: Clinical and Experimental
Cited by 18

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

The efficacy of irreversible and reversible monoamine oxidase inhibitors (MAOIs) in the treatment of social phobia (SP) is well established. Recently, selective serotonin reuptake inhibitors (SSRIs) have been used more frequently. In the present study, the efficacy and side‐effect profile of citalopram, an SSRI, and moclobemide, the only MAOI used in Turkey, were compared. The 71 patients diagnosed with SP according to DSM‐III‐R were randomly assigned to two subgroups; citalopram (n = 36) or moclobemide (n = 35). The study was an 8‐week, randomized, open‐label, rater‐blinded, parallel‐group trial. All patients were assessed by Hamilton anxiety rating (HAM‐A), Liebowitz social anxiety (LSAS), clinical global impression‐severity of illness (CGI‐SI) and clinical global impression‐improvement (CGI‐I) scales. There was a similar percentage of responders (citalopram 75%, n = 27 and moclobemide 74.3%, n = 26), with a >50% or greater reduction in LSAS total score and ratings of ‘very much’ or ‘much improved’ on the CGI‐I. None of the patients withdrew from the study. The results of the present study suggest that citalopram has shown promising results in patients with SP. Copyright © 2002 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.436

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 18

Metadata

Authors
Atmaca, M., Kuloglu, M., Tezcan, E., & Unal, A.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2002-09-17
Volume
17
Issue
8
Pages
401-405
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W2018996292
Cited by
18
References
3
FWCI
1.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.